Antipurinergic Therapy Corrects the Autism-Like Features in the Poly(IC) Mouse Model-Reference-Cited by-同舟云学术

Antipurinergic Therapy Corrects the Autism-Like Features in the Poly(IC) Mouse Model

Published:2013-03-13 Issue:3 Volume:8 Page:e57380
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Naviaux Robert K.,Zolkipli Zarazuela,Wang Lin,Nakayama Tomohiro,Naviaux Jane C.,Le Thuy P.,Schuchbauer Michael A.,Rogac Mihael,Tang Qingbo,Dugan Laura L.,Powell Susan B.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference61 articles.

1. Network- and attribute-based classifiers can prioritize genes and pathways for autism spectrum disorders and intellectual disability;Y Kou;Am J Med Genet C Semin Med Genet,2012

2. The co-morbidity burden of children and young adults with autism spectrum disorders;IS Kohane;PLoS One,2012

3. Recommendations for evaluation and treatment of common gastrointestinal problems in children with ASDs;T Buie;Pediatrics,2010

4. Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlates;EJ Mulder;J Am Acad Child Adolesc Psychiatry,2004

5. Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1;L Palmieri;Mol Psychiatry,2010

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maternal choline supplementation modulates cognition and induces anti-inflammatory signaling in the prefrontal cortices of adolescent rats exposed to maternal immune activation;Brain, Behavior, & Immunity - Health;2024-10

2. Biomarkers of mitochondrial dysfunction in autism spectrum disorder: A systematic review and meta-analysis;Neurobiology of Disease;2024-07

3. Mesenchymal Stem Cells and Purinergic Signaling in Autism Spectrum Disorder: Bridging the Gap between Cell-Based Strategies and Neuro-Immune Modulation;Biomedicines;2024-06-13

4. Metabolic network analysis of pre-ASD newborns and 5-year-old children with autism spectrum disorder;Communications Biology;2024-05-10

5. P2X RECEPTORS AS A NOVEL PROMINENT PHARMACOLOGICAL TARGET FOR VARIOUS CNS DISORDERS [;Fiziolohichnyĭ zhurnal;2024-04-22